Abstract
We compared the results of 44 renal transplants in children, of whom 24 were treated with CS A/AZA and 20 with prednisone in combination with AZA and/or CSA. There were no differences in age distribution or mean ages at transplant between the two treatment groups. The CSA/AZA group had a longer follow-up (29 ± 33 vs 17 ± 18 months). At the last follow-up, five children in the CSA/AZA and none in the prednisone group had lost their grafts. Serum creatinine increased in both groups from 0.7 ± 0.1 mg/dl and 0.9 ± 0.1 mg/dl at the end of the first month to 1.1 ± 0.2 mg/dl in the 36th month (CSA/AZA group) (P< 0.0001) and to 1.5 ± 0.6 mg/dl in the 18th month (prednisone group) (P< 0.05), respectively. Total cholesterol level was 189 ± 52 mg/dl and 178 ± 60 mg/dl and LDL level was 117 ± 48 mg/dl and 115 ± 51 mg/dl for the prednisone and CSA/AZA groups, respectively. HDL was greater in the CSA/AZA group (50 ± 10 vs 41 ± 10 mg/dl) (P<0.03), and VLDL was greater in the prednisone group (31 ± 13 vs 22 ± 8 mg/dl) (P< 0.05). Serum triglyceride was greater in the prednisone group (174 ± 93 vs 112 ± 50 mg/dl) (P<0.03). The standard deviation score for height of the children in the prednisone group did not change (-2.4 ± 1.4 vs -2.1 ± 1.4 SDS), whereas the SDS height score for the CSA/AZA children increased from -3.1 ± 1.7 to -2.6 ± 1.5, -1.9 ± 1.4 and -1.7 ± 1.4, at 12, 24 and 36 months, respectively (P< 0.001). CSA/AZA is a good immunosuppressive regime for the first renal transplant in children, but only 75% tolerated AZA/CSA without same damage to their grafts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kamil ES, Yadin O, Ettenger RB, Boechat MI, Pyke-Grimm K, Nelson PA, Lippe BM, Fine RN (1991) Growth after renal transplantation — a potential role for growth hormone therapy. Clin Transplant 5:208–213
Schorn TF, Kliem V, Bojanovski M, Bojanovski D, Repp H, Bun-zendahl H, Frei Ulrich (1991) Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients. Transplant Int 4:92–95
David-Neto E, Vilares S, Lando V, Nicolau E, Ianhez LE, Sabbaga E, Wajchemberg BL, Arap S (1990) Conversion from azathio-prine/prednisone to azathioprine/cyclosporin improves catch-up growth in pediatric renal transplant recipients. Clin Transplant 4: 229–234
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
David-Neto, E., Nahas, W., Sampaio, E.C., Ianhez, L.E., Sabbaga, E., Arap, S. (1992). CSA/AZA, in the absence of prednisone, improves linear growth in renal transplanted children. In: Kootstra, G., Opelz, G., Buurman, W.A., van Hooff, J.P., MacMaster, P., Wallwork, J. (eds) Transplant International Official Journal of the European Society for Organ Transplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77423-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-77423-2_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55342-7
Online ISBN: 978-3-642-77423-2
eBook Packages: Springer Book Archive